Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
AMGEN TO OPEN NEW SCIENCE & INNOVATION CENTER IN GENOME VALLEY, HYDERABAD
12 Aug 2026
PR Newswire Association LLC.
EQT Life Sciences participates in Vaderis Therapeutics' USD 152 million Series B financing
11 Aug 2026
PR Newswire Association LLC.
NUH RECOGNISED AMONG WORLD'S GREENEST HOSPITALS; ONLY SINGAPORE HOSPITAL AWARDED HIGHEST DISTINCTION
11 Aug 2026
PR Newswire Association LLC.
Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma
10 Aug 2026
GlobeNewswire
Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG
05 Aug 2026
GlobeNewswire
Novo Nordisk wins Dutch court injunction protecting patients from unapproved, unlawful compounded semaglutide nasal spray
05 Aug 2026
PR Newswire Association LLC.
Guido Oelkers to step down as CEO of Sobi in the beginning of 2027
03 Aug 2026
GlobeNewswire
Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan
03 Aug 2026
PR Newswire Association LLC.
BWXT Selling Medical Business to Nordic Capital in Transaction Valued at up to $800 Million
03 Aug 2026
PR Newswire Association LLC.
Manipal Hospital, Bengaluru Installs India's First Elekta Evo, Advancing AI-Enabled Adaptive Radiotherapy in India
31 Jul 2026
GlobeNewswire
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease
31 Jul 2026
GlobeNewswire
Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation
31 Jul 2026
GlobeNewswire
BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets
29 Jul 2026
PR Newswire Association LLC.
Sales of Leqembi® totaled 29.3 billion yen in the second quarter 2026
29 Jul 2026
PR Newswire Association LLC.
AbbVie Announces Availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the Treatment of Platinum-Resistant Ovarian Cancer
29 Jul 2026
PR Newswire Association LLC.
New report identifies opportunities to help more patients in Asia Pacific benefit from advances in AFib care
28 Jul 2026
GlobeNewswire
RECORDATI: SOLID MOMENTUM OF THE GROUP CONTINUES FIRST HALF 2026. NET REVENUE +6.6%, EBITDA +8.8%, ADJUSTED NET INCOME +6.7%
28 Jul 2026
PR Newswire Association LLC.
Ribo Discloses Positive Data from Vortosiran Phase 2a Trial - World's First Clinical Data on siRNA-Mediated FXI Inhibition Following Multiple Dosing in Patients with Coronary Artery Disease
22 Jul 2026
PR Newswire Association LLC.
Takeda's Dengue Vaccine (TAK-003) Becomes India's First Approved Dengue Vaccine, Bringing Prevention to One of the World's Most At-Risk Populations
21 Jul 2026
PR Newswire Association LLC.
Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
17 Jul 2026
GlobeNewswire
Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series
06 Aug 2026
GlobeNewswire
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
06 Aug 2026
GlobeNewswire
Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week
06 Aug 2026
GlobeNewswire
Novo Nordisk raises adjusted sales and adjusted operating profit outlook for 2026
04 Aug 2026
GlobeNewswire
Novo Nordisk reports adjusted operating profit of DKK 33,389 million for Q2 2026 and raises full-year outlook
04 Aug 2026
Upcoming Events All Events
- August 2026
- Online: Biotechgate Digital Partnering August 2026
- September 2026
- Marina Bay Sands: Asia Bio Partnering Forum
- Zurich: HealthVC Summit